Table 3.
Variable | Number patients | PCL-C score
|
Correlation (r) | p-value | F-test | |
---|---|---|---|---|---|---|
Mean | Standard deviation | |||||
Age at enrollment, years | −0.168 | 0.03 | ||||
Gender | ||||||
Male | 25 | 26.2 | 8.6 | 0.60 | ||
Female | 137 | 27.2 | 9.1 | |||
Race/Ethnicity | 0.004 | |||||
White | 119 | 25.9 | 7.8 | 0.008 | ||
Non-white | 43 | 30.2 | 11.1 | |||
Black | 4 | 26.0 | 6.4 | 0.82 | ||
Asian | 15 | 31.4 | 10.2 | 0.05 | ||
Hispanic/Latino | 18 | 27.7 | 2.0 | 0.74 | ||
Other | 6 | 37.2 | 16.9 | 0.005 | ||
Years since diagnosis | 0.045 | 0.57 | ||||
Education | 0.45 | |||||
Less than high school | 3 | 25.3 | 4.6 | 0.74 | ||
High school graduate/GED | 2 | 18 | 1.4 | 0.16 | ||
Some college | 36 | 27.3 | 8.8 | 0.84 | ||
College graduate | 55 | 26.6 | 8.3 | 0.67 | ||
Graduate degree | ||||||
Income (annual) | 0.003 | |||||
<$15,000 | 9 | 30.2 | 11.0 | 0.28 | ||
$16,000–$29,999 | 11 | 27.7 | 8.9 | 0.80 | ||
$30,000–$59,999 | 30 | 32.3 | 11.7 | 0.004 | ||
$60,000–$99,999 | 32 | 25.3 | 7.4 | 0.23 | ||
≥$100,000 | 78 | 25.2 | 7.5 | 0.01 | ||
Marital status | 0.11 | |||||
Married | 91 | 26.6 | 9.3 | 0.50 | ||
Living with partner | 12 | 23.8 | 8.2 | 0.19 | ||
Widowed | 5 | 22.6 | 6.4 | 0.27 | ||
Divorced/separated | 18 | 27.5 | 8.0 | 0.82 | ||
Never married | 36 | 29.6 | 8.9 | 0.05 | ||
Age at diagnosis, years | −0.156 | 0.05 | ||||
Breast cancer | ||||||
Yes | 96 | 26.4 | 9.0 | |||
No | 66 | 27.9 | 9.1 | 0.31 | ||
Lung cancer | ||||||
Yes | 3 | 33.3 | 13.6 | |||
No | 159 | 26.9 | 8.9 | 0.23 | ||
Blood, adult (leukemia/lymphoma) | ||||||
Yes | 12 | 31.83 | 10.4 | |||
No | 150 | 26.7 | 8.8 | 0.07 | ||
Childhood cancer survivor | ||||||
Yes | 40 | 27.8 | 9.0 | |||
No | 122 | 26.8 | 9.1 | 0.54 | ||
Multiple diagnoses | ||||||
Yes | 32 | 28.0 | 9.6 | 0.52 | ||
No | 132 | 26.8 | 8.9 | |||
Chemotherapy | ||||||
Yes | 113 | 27.8 | 9.1 | 0.13 | ||
No | 49 | 25.4 | 8.8 | |||
Radiation | ||||||
Yes | 121 | 26.9 | 9.2 | 0.75 | ||
No | 41 | 27.4 | 8.6 | |||
Surgery | ||||||
Yes | 132 | 26.8 | 8.9 | 0.51 | ||
No | 30 | 28.0 | 9.8 | |||
Social support (ESSI) | ||||||
High support | 123 | 25.3 | 7.5 | 0.000 | ||
Low support | 39 | 32.5 | 11.2 | |||
Depressive symptom score (CES-D) | ||||||
Score less than 16 | 119 | 23.7 | 5.6 | 0.000 | ||
Score 16 and above | 43 | 36.2 | 10.1 | |||
SF-36 PCS | −0.374 | 0.000 | ||||
SF-36 MCS | −0.620 | 0.000 | ||||
IOC PIS | 0.103 | 0.191 | ||||
IOC NIS | 0.628 | 0.000 |
ESSI, ENRICHD Social Support Instrument; CES-D, Center for Epidemiologic Studies Depressive Symptoms instrument; SF-36 PCS, Physical Component Summary Score; SF-36 MCS, Mental Component Summary Score; IOC PIS, Impact of Cancer Positive Impact Summary Score; IOC NIS, Impact of Cancer Negative Impact Summary Score.